Michael Werner Executive Director for the Alliance of Regenerative Medicine Discusses Advocacy, Regulatory Efforts, And Getting Products to Market at BioPharm America Boston 2011
This is a very important area of focus today as regenerative medicine offers both cures and treatments and also creates jobs, an added plus. If you have followed any of the news in this area you may be aware of organs being grown in labs, etc. Diabetes is a huge area of focus for regenerative medicine with stem cells and other types of emerging treatments. Foot ulcers for diabetics is one example of how regenerative medicine is work in progress and saves patients from amputations.
The Alliance is only a couple years old and is a non-profit organization and the members are varied in what they do, as they come from Pharma, advocacy groups, medical device companies, investors and more. All come together to fight for policies that will benefit translational medicine. Our healthcare blog that we sponsor, the Medical Quack has more specific information and updates related to regenerative medicine you might want to check out with how some of the processes take place and where.
The Alliance is very busy working with CMS, the FDA and even Congress to help get valuable products to market. A company who joins the alliance actually has a speaking role in how reimbursements, regulations and so forth are being created.
Micro-Cap Review Latest Issue
Cavaet Emptor or Buyer Beware by SNN Inc. CEO Sheldon “Shelly” Kraft
Check out the book "Caveat Emptor" written by CEO Sheldon Kraft, click on the image to view a preview and the full book can be purchased for $15.95.
There are some best practices and good hints on what to look out for in today’s volatile markets.